https://orcid.org/0000-0002-2513-4721
Figures & data
Figure 1 Prevalent direct costs attributable to head and neck squamous cell carcinoma (HNSCC) care in 2012 in France (in million €)
Table 1 Per-patient clinical outcomes and direct costs over 3 years
Table 2 Clinical outcomes and direct costs of HNSCC, by phase-of-care
Figure 2 Mean monthly costs of head and neck squamous cell carcinoma (HNSCC), by phase-of-care and main cost category.
Notes: Direct costs include reimbursements to public/private hospitals in acute and post-acute care, out-of-pocket expenses for inpatient stays, radiation therapy imputed in the private sector, and medical transportation to/from hospital.
Data availability
Access to the French National Hospital Discharge (PMSI) database is restricted by French law.